Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGRIFLU versus comparator trivalent inactivated influenza vaccine in healthy adults aged 50 years and older
2012-003740-74Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza vaccine and influenza vaccine, inactivated, subunit, trivalent in influenza (2 arms), sponsored by Novartis. Primary endpoint: Primary immunogenicity endpoint. Started Jul 2013; status: completed.
02
Drugs
influenza vaccineinfluenza vaccine, inactivated, subunit, trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-003740-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003740-74.